Position in OLMA
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$8,443,560
-$54,482 QoQ
Shares Held
674,945
+18.4% QoQ
Ownership
0.771%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#29
of 182 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 98%
Shared 2%
None 0%
Common Shares in OLMA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026NORTHERN TRUST CORP holds $7,813,607,781 across 424 Biotechnology names. OLMA ranks #125 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,486,478 | $1,235,108,212 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
916,467 | $571,453,829 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
886,900 | $266,983,504 | |
| 4 | RPRX |
Royalty Pharma plc
|
4,718,859 | $264,586,419 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
1,117,110 | $209,212,357 | |
| 6 | MRNA |
Moderna, Inc.
|
2,985,329 | $209,062,587 | |
| 7 | INCY |
Incyte Corp
|
1,761,966 | $199,736,460 | |
| 8 | CYTK |
Cytokinetics Inc
|
1,647,345 | $140,337,319 |
All Filings in OLMA
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,443,560 | 674,945 | Shares | Other | 2026-08-13 | |
| 2026-03-31 | $8,498,042 | 569,956 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $11,133,175 | 445,327 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $4,728,881 | 483,032 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $2,127,545 | 499,424 | Shares | Other | 2025-08-13 | |
| 2025-03-31 | $1,571,998 | 418,085 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $2,470,676 | 423,787 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $4,653,423 | 389,734 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $3,722,966 | 344,082 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $3,952,455 | 349,157 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $4,950,035 | 352,818 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $3,721,363 | 301,325 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $2,661,646 | 294,756 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $253,281 | 72,992 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $165,663 | 67,618 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $186,948 | 67,735 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $245,013 | 60,200 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $983,561 | 230,883 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $2,350,370 | 251,108 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $6,787,062 | 246,265 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $3,733,705 | 133,442 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $4,316,981 | 130,108 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $668,408 | 13,902 | Shares | Other | 2021-02-11 | |
| No filing history on record for this holder in this stock. | ||||||